Giant left main coronary artery aneurysm initially seen as an acute coronary syndrome

1995 ◽  
Vol 129 (6) ◽  
pp. 1216-1217 ◽  
Author(s):  
James P. Olson ◽  
Roger F. Chamusco
2021 ◽  
pp. 1-2
Author(s):  
Claudiu Ungureanu ◽  
Manuel Mignon ◽  
Antoine de Meester ◽  
Joseph Dens

2006 ◽  
Vol 23 (5) ◽  
pp. 430-431 ◽  
Author(s):  
S. Anandaraja ◽  
Saibal Mukhopadhyay ◽  
Sunil Roy ◽  
Sanjeev Kathuria ◽  
Sanjay Tyagi

Angiology ◽  
1996 ◽  
Vol 47 (6) ◽  
pp. 615-619
Author(s):  
Akihisa Tomaru ◽  
Makoto Kudou ◽  
Jun Baba ◽  
Yoshihisa Goto ◽  
Shigeru Miura ◽  
...  

2011 ◽  
Vol 13 (02) ◽  
pp. 89-91
Author(s):  
Chun-Yao Huang ◽  
Cheng-Hsiung Huang ◽  
Jaw-Wen Chen ◽  
Shing-Jong Lin ◽  
Tse-Min Lu

2016 ◽  
Vol 11 (9) ◽  
pp. 1080-1082
Author(s):  
Julian O.M. Ormerod ◽  
Joanna Lim ◽  
Badri Chandrasekaran ◽  
Steve Ramcharitar ◽  
Scot Garg ◽  
...  

Circulation ◽  
2020 ◽  
Vol 142 (Suppl_3) ◽  
Author(s):  
Haruko Shiota ◽  
Eisuke Kagawa ◽  
Masaya Kato ◽  
Noboru Oda ◽  
Eiji Kunita ◽  
...  

Introduction: Mortality in patients with acute coronary syndrome (ACS) due to unprotected left main coronary artery (LMA) occlusion is high. Extracorporeal membrane oxygenation (ECMO) could rapidly provide circulatory support. Hypothesis: This study aimed to verify the hypotheses that the patient who required circulatory support with ECMO in acute phase of LMA-ACS had greater cardiac function deterioration and had higher mortality in the chronic phase than those who did not require ECMO. Methods: Patients with LMA-ACS who underwent percutaneous coronary revascularization between 2000 and 2020 were enrolled in this study. The patients were divided into two groups based on whether or not they received ECMO. Thirty-day (acute phase) and 30-day to 6-year (chronic phase) survival curves were constructed by Kaplan-Meier method. The cause of death in acute and chronic phase were examined. Results: Among the 85 study patients, 23 (27%) were in the ECMO-group. Median age was younger in the ECMO-group (65 y [57 - 72] vs. 73 y [69 - 83], p < 0.01), and male sex (67% vs. 63%) were similar in ECMO group and non-ECMO groups respectively. The prevalence of ST elevation myocardial infarction (STEMI), non-STEMI, unstable angina were 52%, 48%, and 0% vs. 15%, 42%, and 44% in the ECMO group and non-ECMO group, respectively. The 30-day mortality was significantly higher in ECMO group (61% vs. 15%, p < 0.01); however, the 30-day to 6-year mortality was similar between the two groups (41% vs. 33%, p = 0.59) (Figure). The cause of death in the acute phase were cardiac failure (79% and 67%) and those in chronic phase were cardiac failure (50% and 25%), malignancy (0% and 13%), and infection (50% and 36%). Conclusions: The mortality in chronic phase in LMA-ACS patients who survived up to 30 days were similar in ECMO group and non-ECMO group. Moreover the patients whose cardiac function deteriorated severely and required ECMO in acute phase had similar prognosis to those that did not require ECMO.


Sign in / Sign up

Export Citation Format

Share Document